Shona Hendry

3.0k total citations
22 papers, 614 citations indexed

About

Shona Hendry is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Shona Hendry has authored 22 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 5 papers in Surgery. Recurrent topics in Shona Hendry's work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (7 papers) and Sarcoma Diagnosis and Treatment (5 papers). Shona Hendry is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (7 papers) and Sarcoma Diagnosis and Treatment (5 papers). Shona Hendry collaborates with scholars based in Australia, Netherlands and South Korea. Shona Hendry's co-authors include Stephen B. Fox, Benjamin Solomon, David J. Byrne, Steven A. Stacker, Marc G. Achen, Rae H. Farnsworth, Wendy A. Cooper, Sue Sturrock, Gavin Wright and Daniel Steinfort and has published in prestigious journals such as Clinical Cancer Research, Frontiers in Immunology and Oncotarget.

In The Last Decade

Shona Hendry

21 papers receiving 612 citations

Peers

Shona Hendry

ONCOL

PRM

IMMUN

Maria Fenton-Kerimian United States

Paweł Teterycz Poland

Johannes Andel Austria

Fergus Noble United Kingdom

María A. García-Márquez Germany

Xin Sun China

Louise Jackett Australia

Adel K. El-Naggar United States

Shamayel Mohammed Saudi Arabia

Marie Alt France

Maria Fenton-Kerimian United States

Shona Hendry

471 ×1.0

ONCOL

200 ×0.9

PRM

288 ×2.0

IMMUN

280 ×2.5

59 ×0.6

Citations per year, relative to Shona Hendry Shona Hendry (= 1×) peers Maria Fenton-Kerimian

Countries citing papers authored by Shona Hendry

Since Specialization

Citations

This map shows the geographic impact of Shona Hendry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shona Hendry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shona Hendry more than expected).

Fields of papers citing papers by Shona Hendry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shona Hendry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shona Hendry. The network helps show where Shona Hendry may publish in the future.

Co-authorship network of co-authors of Shona Hendry

This figure shows the co-authorship network connecting the top 25 collaborators of Shona Hendry. A scholar is included among the top collaborators of Shona Hendry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shona Hendry. Shona Hendry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Daniel, et al.. (2025). Revisiting a soft tissue pathology heresy: a clinicopathological study of 17 retroperitoneal lipomas (with comparison to well-differentiated liposarcoma). Pathology. 57(4). 450–454.

Hendry, Shona, Nima Mesbah Ardakani, Connull Leslie, et al.. (2023). Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancer. Pathology. 55(7). 917–921. 1 indexed citations

Hendry, Shona, Kanishka Rangamuwa, Hao Wang, et al.. (2022). Programmed Death-Ligand 1 Copy Number Loss in NSCLC Associates With Reduced Programmed Death-Ligand 1 Tumor Staining and a Cold Immunophenotype. Journal of Thoracic Oncology. 17(5). 675–687. 12 indexed citations

Wong, Lih‐Ming, et al.. (2020). Prostate sarcomas: A radiological mimic for benign prostatic hyperplasia. Urology Case Reports. 31. 101192–101192. 5 indexed citations

Snow, Hayden, Catherine Mitchell, Shona Hendry, et al.. (2020). Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapy. Journal of Surgical Oncology. 123(1). 117–126. 10 indexed citations

Millen, Rosemary, Shona Hendry, Vignesh Narasimhan, et al.. (2020). CD8⁺ tumor‐infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival. Clinical & Translational Immunology. 9(7). e1155–e1155. 6 indexed citations

Snow, Hayden, Shona Hendry, Catherine Mitchell, et al.. (2020). Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single‐centre study. ANZ Journal of Surgery. 90(4). 497–502. 13 indexed citations

Hendry, Shona, et al.. (2019). Novel multiplex droplet digital PCR assay for scoring PD-L1 in non-small cell lung cancer biopsy specimens. Lung Cancer. 134. 233–237. 25 indexed citations

Hendry, Shona, Janine A. Danks, John Slavin, et al.. (2019). A Novel Approach to Detect Programed Death Ligand 1 (PD-L1) Status and Multiple Tumor Mutations Using a Single Non–Small-Cell Lung Cancer (NSCLC) Bronchoscopy Specimen. Journal of Molecular Diagnostics. 21(2). 186–197. 11 indexed citations

10.

Hendry, Shona, David J. Byrne, Michael Christie, et al.. (2019). Adequate tumour cellularity is essential for accurate PD‐L1 immunohistochemistry assessment on cytology cell‐block specimens. Cytopathology. 31(2). 90–95. 19 indexed citations

11.

Solomon, Benjamin, Richard J. Young, Mathias Bressel, et al.. (2018). Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma. Cancer Immunology Research. 6(3). 295–304. 100 indexed citations

12.

Kok, David L., et al.. (2018). Iatrogenic subcutaneous metastasis from WHO Grade I intracranial meningioma. Journal of Clinical Neuroscience. 58. 224–225. 8 indexed citations

13.

Thapa, Bibhusal, Gareth Rivalland, Carmel Murone, et al.. (2018). OA08.05 Quantifying Tumour Infiltrating Lymphocytes (TILs) in Malignant Pleural Mesothelioma (MPM) -Defining the Hot, the Warm and the Cold Tumours.. Journal of Thoracic Oncology. 13(10). S339–S339. 1 indexed citations

14.

Snow, Hayden, Jessica Head, Alan Herschtal, et al.. (2018). Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre. ANZ Journal of Surgery. 88(11). 1151–1157. 12 indexed citations

15.

Soo, Ross A., Bernadette Reyna Asuncion, Zul Fazreen, et al.. (2018). Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples. Oncotarget. 9(6). 6841–6851. 15 indexed citations

16.

Hendry, Shona, David J. Byrne, Gavin Wright, et al.. (2017). Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer. Journal of Thoracic Oncology. 13(3). 367–376. 125 indexed citations

17.

Hendry, Shona, Jia‐Min Pang, David J. Byrne, et al.. (2017). Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features. Clinical Cancer Research. 23(17). 5210–5217. 57 indexed citations

18.

Hendry, Shona, Rae H. Farnsworth, Benjamin Solomon, et al.. (2016). The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment. Frontiers in Immunology. 7. 621–621. 149 indexed citations

19.

Hendry, Shona & Cynthia H. Forrest. (2014). Epithelioid Angiosarcoma Arising in an Adrenal Cortical Adenoma. International Journal of Surgical Pathology. 22(8). 744–748. 11 indexed citations

20.

Affandi, Jacquita S., Shona Hendry, Grant Waterer, et al.. (2013). Searching for an immunogenetic factor that will illuminate susceptibility to non-tuberculous mycobacterial disease. Human Immunology. 74(10). 1382–1385. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact